eli lilly & co (LLY:New York)
Chairman, Member of Transaction Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, AMAG Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 64 board members in 7 different organizations across 9 different industries.|
See Board Relationships
Mr. Gino Santini served as a Senior Vice President of Corporate Strategy and Business Development at Eli Lilly and Company from June 2007 to December 2010. Mr. Santini led corporate strategy and long-range planning, M&A, new product licensing, innovative financing of internal development projects and the expansion of Lilly Ventures in the U.S. and China. He served as President of U.S. Operations at Eli Lilly and Company from 1999 to 2004. He served as the Senior Vice ...
Lilly Corporate CenterPhone: 317-276-2000
Indianapolis, Indiana 46285
Board Members Memberships*
Chairman, Member of Transaction Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Independent Director and Member of Related-Party Transaction Committee
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Business Development Committee
Former Member of The Board of Directors
University of Rochester
Bachelor's Degree 1981
Universita' di Bologna
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert L. Chioini||Founder, Chairman, Chief Executive Officer, President and Member of Stock Option Committee|
Rockwell Medical, Inc.
|Robert Maurice Powell Jr.||Chairman of the Management Board for Fresenius Medical Care Management AG and Chief Executive Officer of Fresenius Medical Care Management AG|
Fresenius Medical Care AG & Co. KGAA
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|David R. Ebsworth Ph.D.||Chief Executive Officer, Head of the Pharma Division and Chief Executive Officer of Vifor Pharma & Om Pharma|
|SFr.1.4M||Compensation as of Fiscal Year --.|